Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
Open Access
- 30 September 2013
- journal article
- review article
- Published by Wiley in Disease Markers
- Vol. 35 (5) , 413-418
Abstract
Lectin-like oxidized low density lipoprotein receptor-1 (LOX-1), the main oxidized low-density lipoprotein (OxLDL) in endothelial cells, is upregulated in atherosclerotic lesions and is involved in several cellular processes that regulate the pathogenesis of atherosclerosis. The LOX-1 expressed on the cell surface can be proteolytically cleaved and released in a soluble form (sLOX-1) in the circulation under pathological conditions. Serum levels of sLOX-1, in fact, are elevated at the early stages of acute coronary syndrome and are associated with coronary plaque vulnerability and with the presence of multiple complex coronary lesions. Moreover, in subjects with stable CAD, levels of serum sLOX-1 are associated with the presence of lesions in the proximal and mid-segments of the left anterior descending artery that are the most prone to rupture; in subjects undergoing percutaneous coronary intervention, baseline preprocedural serum sLOX-1 levels are associated with the incidence of periprocedural myocardial infarction. Altogether, these findings suggest that circulating levels of sLOX-1 might be a diagnostic and prognostic marker for atherosclerotic-related events.Keywords
This publication has 37 references indexed in Scilit:
- Postprocedural serum sLOX-1 levels are associated with coronary in-stent restenosis in patients with stable coronary artery diseaseCoronary Artery Disease, 2011
- CRP enhances soluble LOX-1 release from macrophages by activating TNF-α converting enzymeJournal of Lipid Research, 2011
- Circulating Soluble Lectin‐Like Oxidized Low‐Density Lipoprotein Receptor‐1 Levels Are Associated With Angiographic Coronary Lesion Complexity in Patients With Coronary Artery DiseaseClinical Cardiology, 2011
- Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 as an Early Biomarker for ST Elevation Myocardial Infarction - Time-Dependent Comparison With Other Biomarkers -Circulation Journal, 2011
- Serum sLOX-1 levels are associated with the presence and severity of angiographic coronary artery disease in patients with metabolic syndromeClinical & Investigative Medicine, 2010
- Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotectionEuropean Heart Journal, 2010
- Caloric restriction, aerobic exercise training and soluble lectin-like oxidized LDL receptor-1 levels in overweight and obese post-menopausal womenInternational Journal of Obesity, 2010
- Soluble lectin-like oxidized LDL receptor-1 (sLOX-1) as a sensitive and specific biomarker for acute coronary syndrome—Comparison with other biomarkersJournal of Cardiology, 2010
- The Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 and its Soluble Form: Cardiovascular ImplicationsJournal of Atherosclerosis and Thrombosis, 2010
- Weight reduction can decrease circulating soluble lectin-like oxidized low-density lipoprotein receptor–1 levels in overweight middle-aged menMetabolism, 2009